KALA BIO, Inc. (KALA): restructuring charge — KALA BIO faces asset foreclosure by Oxford; CEO terminated, all staff reduced, expects delisting

KALA BIO, Inc.

Oxford Finance forecloses on all assets, swept substantially all cash; still owed ~$9.6M.
Board terminated all employees not needed for foreclosure; CEO Todd Bazemore terminated without cause but stays as director/PEO.
Company expects no distributions to stockholders or unsecured creditors after foreclosure.
Company anticipates inability to file future SEC reports and delisting from Nasdaq.

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

KALA BIO, Inc. announced a restructuring affecting Company's remaining assets (terminated all remaining employees not deemed necessary by Oxford to execute a foreclosure of the Company’s assets).

Type: restructuring
Affected area: Company's remaining assets
Headcount: terminated all remaining employees not deemed necessary by Oxford to execute a foreclosure of the Company’s assets

Exact text from the filing

On October 19, 2025, the Board terminated all remaining employees not deemed necessary by Oxford to execute a foreclosure of the Company’s assets (the “Reduction”).

View on SEC.gov

6 restructurings & charges filed in the last 30 days. Browse all restructurings & charges →

KALA BIO, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-100620

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.